Nanjing Leads Biolabs Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	1,221	372.54	247.52
Short-Term Investments	326.89	-	-
Trading Asset Securities	-	166.18	100.13
Cash & Short-Term Investments	1,548	538.72	347.65
Cash Growth	187.36%	54.96%	-
Inventory	58.02	-	-
Other Current Assets	84.17	57.59	19.47
Total Current Assets	1,690	596.31	367.12
Property, Plant & Equipment	49.02	47.57	61.09
Other Intangible Assets	1.76	-	-
Other Long-Term Assets	40.42	25.57	19.27
Total Assets	1,781	669.44	447.48
Accounts Payable	6.49	3.52	0.22
Accrued Expenses	41.87	34.26	23.33
Current Portion of Long-Term Debt	260.09	255.21	61
Current Portion of Leases	7.07	5.72	4.31
Current Income Taxes Payable	0.98	0.78	0.9
Current Unearned Revenue	178.21	84.22	-
Other Current Liabilities	7.5	14.63	1,305
Total Current Liabilities	502.2	398.34	1,395
Long-Term Leases	13.4	5.55	1.78
Total Liabilities	515.61	403.88	1,396
Common Stock	198.89	156.5	17.02
Retained Earnings	-406.98	-195.56	-982.76
Treasury Stock	-72.67	-	-
Comprehensive Income & Other	1,547	304.62	16.93
Shareholders' Equity	1,266	265.56	-948.81
Total Liabilities & Equity	1,781	669.44	447.48
Total Debt	280.56	266.48	67.09
Net Cash (Debt)	1,267	272.24	280.57
Net Cash Growth	365.57%	-2.97%	-
Net Cash Per Share	7.28	1.81	1.94
Filing Date Shares Outstanding	198.89	156.5	144.85
Total Common Shares Outstanding	198.89	156.5	144.85
Working Capital	1,188	197.97	-1,027
Book Value Per Share	6.36	1.70	-6.55
Tangible Book Value	1,264	265.56	-948.81
Tangible Book Value Per Share	6.36	1.70	-6.55
Machinery	82.65	75.61	74.21
Construction In Progress	1	-	0.36
Leasehold Improvements	25.85	25.85	24.63